Disclosure Of First-Time Adoption [Text Block]

ABIONYX Pharma - Filing #2821124

Concept 2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
176 730 EUR
1 232 EUR
30,000 EUR
39,000 EUR
11 797 EUR
170 322 EUR
6 629 EUR
11 699 EUR
25,000 EUR
92,000 EUR
168 621 EUR
6 666 EUR
174 818 EUR
1 097 EUR
11 601 EUR
25,000 EUR
947,000 EUR
167 832 EUR
176 595 EUR
3 838 EUR
78,000 EUR
Comprehensive income
1 891 EUR
1 849 EUR
Profit (loss)
1 886 EUR
1 886 EUR
1 849 EUR
1 849 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.